Circulating nucleic acids in plasma and serum: An overview

Annals of the New York Academy of Sciences

Volumn 945, Issue , 2001, Pages 1-7

  Dennis Lo, Y M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer detection; Circulating RNA; Noninvasive prenatal diagnosis; Organ transplantation; Overview; Plasma DNA

Indexed keywords

DNA; FETAL DNA; NUCLEIC ACID; RNA; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; CANCER DIAGNOSIS; CHIMERA; CONFERENCE PAPER; FETUS; HUMAN; MALARIA; MATERNAL PLASMA; NUCLEIC ACID ANALYSIS; ORGAN TRANSPLANTATION; PLASMA; PLASMODIUM; PREGNANCY; PRENATAL DIAGNOSIS; SERUM; TUMOR DNA;

EID: 0034750635     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03858.x     Document Type: Conference Paper

References (50)

1. Les acides nucléiques du plasma sanguin chez l'homme
2. Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus
3. Free DNA in the serum of cancer patients and the effect of therapy
4. Neoplastic characteristics of the DNA found in the plasma of cancer patients
5. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia
6. Soluble normal and mutated DNA sequences from single-copy genes in human blood
7. Microsatellite alterations in plasma DNA of small cell lung cancer patients
8. Microsatellite alterations in serum DNA of head and neck cancer patients
9. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer
10. Molecular detection of genetic alterations in the serum of colorectal cancer patients
11. Detection of erbB-2 amplifications in tumors and sera from esophageal carcinoma patients
12. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma
13. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma
14. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma
15. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma
16. Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma
17. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA
18. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies
19. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease
20. Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma
21. Human papillomavirus DNA in plasma of patients with cervical cancer
22. Aberrant patterns of DNA methylation, chromatin formation, and gene expression in cancer
23. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients
24. Relationship of p16 methylation status and serum α-fetoprotein concentration in hepatocellular carcinoma patients
25. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients
26. Quantitative analysis of aberrant p16 methylation using realtime quantitative methylation-specific polymerase chain reaction
27. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma
28. Prenatal sex determination by DNA amplification from maternal peripheral blood
29. Two-way cell traffic between mother and fetus: Biologic and clinical implications
30. Presence of fetal DNA in maternal plasma and serum
31. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis
32. Fetal DNA in maternal plasma: Biology and diagnostic applications
33. Chimerism after organ transplantation
34. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum
35. Presence of donor-specific DNA in plasma of kidney and liver transplant recipients
36. Detection of Plasmodium falciparum DNA in plasma
37. Plasma DNA as a prognostic marker in trauma patients
38. The origin and mechanism of circulating DNA
39. Plasma DNA as a marker of cancerous cell death: Investigations in patients suffering from lung cancer and in nude mice bearing human tumors
40. Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen
41. Fate of injected deoxyribonucleic acid in mice
42. Rapid clearance of fetal DNA from maternal plasma
43. Genetic analysis of DNA excreted in urine: A new approach for detecting specific genomic DNA sequences from cells dying in an organism
44. Molecular testing of urine: Catching DNA on the way out
45. Tumor DNA circulating in the plasma might play a role in metastasis: The hypothesis of the genometastasis
46. Horizontal transfer of DNA by the uptake of apoptotic bodies
47. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma
48. Detection of tumor messenger RNA in the serum of patients with malignant melanoma
49. Telomerase RNA as a detection marker in the serum of breast cancer patients
50. Presence of fetal RNA in maternal plasma